Search
for
Sort by
Research 541–570 of 1000+
- New Treatment Strategies in Management of Alopecia Areata: Review Article
- Exploring the Role of Hirudotherapy in Alopecia Areata: Immunological and Microcirculatory Perspectives.
- Dupilumab Associated Progression of Alopecia Areata to Alopecia Universalis: A Case Report
- Hair restoration and regenerative medicine: Scope, science, and the road ahead
- Efficacy and safety of janus kinase inhibitors in the treatment of alopecia areata in children
- Characterizing Lipid Changes and Use of Lipid-Lowering Medications in Patients With Alopecia Areata Treated With Baricitinib: Integrated Results From the BRAVE-AA1 and -AA2 Clinical Trials
- Treatment Challenges in Alopecia Areata: Insights From a Case of Baricitinib Therapy Failure
- The pharmacological treatment of alopecia areata
- Investigating the roles of cellular senescence in embryogenesis and aging
- Alopecia Areata: Current Review
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Immune therapies for alopecia areata: evidence and new perspectives
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- Recent Advances in Drug Development for Hair Loss
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Topical Ruxolitinib for the Treatment of Alopecia Universalis
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- Resident Memory T Cells in Autoimmune Skin Diseases
- Stem cells supporting other stem cells
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Shared Decision-Making, Therapeutic Choice, and Decisional Regret in Patients With Alopecia Areata
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Innovative strategies for the discovery of new drugs against alopecia areata: taking aim at the immune system
- Janus Kinase Inhibitors for Alopecia Areata
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences